Omicron keeps churning out new variants, each being a little more infectious and a little bit further away from the original strains of COVID.
COVID-19 Epidemiology, Therapeutics, and Vaccine Developments
Looking at the dynamics of the epidemic, in North America, cases are up by about 13%, including over 25% in the United States.
COVID-19 Epidemiology, Mitigation, and Omicron Subvariants
Most areas of the world are shifting in mindset, from pandemic to endemic, what does that mean for day-to-day life?
COVID-19 Epidemiology, Travel, and Testing
For at least a few months maybe even into next year, it is very likely that people will continue to catch COVID at reasonably high rates.
Second Booster Shot
This week, the FDA and CDC updated their authorization and guidelines to allow certain individuals to be eligible for another mRNA booster.
COVID-19 Epidemiology, BA2, and Boosters
Last week was the second anniversary of the initial declaration of a national emergency related to COVID on March 13.
Epidemiology, Variants, Boosters, and Long COVID
Over the coming week, we will have the 2-year anniversaries of the first Emergency Declaration by President Trump and the first school closures.
COVID-19 Epidemiology, CDC Risk Ranking, and Treatments
The downward trend in case numbers throughout the Americas has continued, with the 7-day average of cases down 30% in the last week.
COVID-19 Epidemiology, Boosters, and CDC Data
The US CDC acknowledged that they have been withholding various aspects of statistical analysis out of fears that the data could be misinterpreted.
Omicron BA.2, Epidemiology, and Clinical Medicine Developments
Most areas in Europe have seen, or will shortly see, the removal of vaccine passport restrictions in most settings.